X

LATEST

Advanced Micro Devices sees recovery in second half. Is the stock a buy?

Semiconductor company Advanced Micro Devices, Inc. (NASDAQ: AMD) had an unimpressive start to the new fiscal year, reporting weak numbers…

Shake Shack Inc Class A (SHAK) Q1 2023 Earnings Call Transcript

Shake Shack Inc Class A (NYSE: SHAK) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Annalee Leggett -- Director of…

Blue Apron Holdings Inc (APRN) Q1 2023 Earnings Call Transcript

Blue Apron Holdings Inc (NYSE: APRN) Q1 2023 Earnings Call dated May. 04, 2023  Corporate Participants: Linda Findley Kozlowski --…

Papa Johns International Inc (PZZA) Q1 2023 Earnings Call Transcript

Papa Johns International Inc (NASDAQ:PZZA) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Stacy Frole -- Vice President of Investor…

Trxade Health Inc. (NASDAQ: MEDS) Q1 2023 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that operates as an integrated drug procurement and delivery platform.…

Ocean Biomedical reports new results validating tumor suppression with anti-Chi3L1 antibody: EF Hutton raises OCEA price target to $17

Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said its scientific co-founder Jack Elias published new findings in Cancer Research,…

Ocean Biomedical co-founder Jonathan Kurtis presents detailed data on malaria vaccine at conference

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and…

Ocean Biomedical co-founder Jack Elias to receive US patent for pulmonary fibrosis treatments

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and…

JB Hunt Transport Services Inc. (JBHT) Q1 2023 Earnings Call Transcript

JB Hunt Transport Services Inc. (NASDAQ: JBHT) Q1 2023 earnings call dated Apr. 17, 2023 Corporate Participants: Brad Delco -- Senior Vice…

Ocean Biomedical (OCEA) announces $134 million financial backing for innovative research and IND filings

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing…